More importantly, CRISPR-Cas13a-mediated mRNA downregulation can induce apoptosis of mouse tumor cells and cause significant tumor atrophy in vitro, and CRISPR-Cas13a knockdown of KRAS-G12D can block the proliferation of pancreatic cancer cells. This evidence concerns the gene KRAS and familial pancreatic carcinoma.